Literature DB >> 1725908

Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries.

J V Mombouli1, P M Vanhoutte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725908     DOI: 10.1097/00005344-199112000-00021

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  7 in total

1.  Endothelial AT(2)-receptors: chicken or egg?

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 2.  Endothelial function and bradykinin in humans.

Authors:  B Hornig; H Drexler
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 3.  ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.

Authors:  J V Mombouli
Journal:  Drugs       Date:  1997       Impact factor: 9.546

4.  Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition.

Authors:  Birger Hesse; Christian Meyer; Flemming S Nielsen; Asako Sato; Jens D Hove; Soeren Holm; Lia E Bang; Klaus F Kofoed; Tage L Svendsen; Hans-Henrik Parving; Lionel H Opie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-05       Impact factor: 9.236

5.  Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training.

Authors:  J V Mombouli; M Nakashima; M Hamra; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

6.  Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.

Authors:  S Mittra; M Singh
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

7.  Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats.

Authors:  P Murray; B Pitt; R C Webb
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.